在L3T4+细胞毒性T淋巴细胞的下调中,由白素-2进行调节
1Department of Pediatrics, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee 53233.
概括
介质素-2 (IL-2) 驱动细胞毒性T淋巴细胞 (CTL) 增殖,但可以矛盾地降低某些抗原特异性CTLs的杀伤能力. 这些T细胞可以恢复功能,在扩张过程中显示细胞分解的动态调节.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 干白素-2 (IL-2) 对T细胞增殖至关重要,并用于扩大细胞毒性T淋巴细胞 (CTLs) 进行研究.
- CTLs是识别外来抗原的关键免疫细胞.
研究的目的:
- 研究IL-2对抗原特异性CTLs的功能活性的影响.
- 了解IL-2如何影响在增殖过程中的CTL细胞分解功能.
主要方法:
- 使用了涉及CTLs的实验室研究,这些CTLs特定于小鼠II类抗原I-Ek.
- 应用特定抗原和重组IL-2的交替信号来调节CTL活动.
- 监测了活动和增殖的变化.
主要成果:
- IL-2降低了某些II类特异性CTLs的溶解活性,这种活性取决于剂量和时间.
- L3T4+ CTLs的炎症活性是由IL-2和抗原暴露可逆调节的.
- 尽管IL-2诱导的增殖,但CTLs保持了抗原特异性和恢复到Lytic表型的能力.
结论:
- 抗原特异性CTL可以在IL-2驱动的增殖过程中调节它们的细胞分解功能.
- 这种调制发生在不损害抗原特异性或恢复完全光化能力的潜力的情况下.
- 在CTL扩张中IL-2的作用是复杂的,涉及到效应器功能的动态调节.
相关概念视频
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


